Found: 10
Select item for more details and to access through your institution.
Mavoglurant in Parkinson's patients with l-Dopa-induced dyskinesias: Two randomized phase 2 studies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease.
- Published in:
- Movement Disorders, 2009, v. 24, n. 4, p. 541, doi. 10.1002/mds.22343
- By:
- Publication type:
- Article
Effects of Rivastigmine in Alzheimer's Disease Patients with and Without Hallucinations.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 20, n. 1, p. 301, doi. 10.3233/JAD-2010-1362
- By:
- Publication type:
- Article
Cover Image, Volume 22, Issue 7.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1, doi. 10.1111/dom.14113
- By:
- Publication type:
- Article
Efficacy and safety of dual add‐on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52‐week, randomized, active‐controlled trial
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1083, doi. 10.1111/dom.13997
- By:
- Publication type:
- Article
Dapagliflozin plus saxagliptin add‐on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1094, doi. 10.1111/dom.14004
- By:
- Publication type:
- Article
Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add‐on to metformin with or without sulphonylurea in patients with type 2 diabetes: A randomized, parallel‐design, open‐label, Phase 3 trial
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 6, p. 957, doi. 10.1111/dom.13981
- By:
- Publication type:
- Article
Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add‐on to metformin in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 11, p. 2598, doi. 10.1111/dom.13437
- By:
- Publication type:
- Article
Dapagliflozin Added to Verinurad Plus Febuxostat Further Reduces Serum Uric Acid in Hyperuricemia: The QUARTZ Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Dapagliflozin Plus Saxagliptin Add-on Therapy Compared With Insulin in Patients With Type 2 Diabetes Poorly Controlled by Metformin With or Without Sulfonylurea Therapy: A Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article